Introduction
Targeted therapies have transformed the treatment of blood cancers by offering improved outcomes with better tolerability. BORVIZ 2 Tablets are widely used in the management of multiple myeloma. At Unnati Pharmax, we specialize in the export of BORVIZ 2 from India, ensuring consistent quality, regulatory compliance, and timely global supply.
This blog covers BORVIZ 2 uses, composition, working mechanism, dosage, side effects, and export information to help buyers and healthcare professionals make informed decisions.
What is BORVIZ 2?
BORVIZ 2 contains Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma and certain lymphomas. It interferes with cancer cell survival pathways, leading to controlled cancer cell death.
Because of its targeted mechanism, BORVIZ 2 is an essential drug in modern hematological oncology.
Uses of BORVIZ 2 Tablets
BORVIZ 2 is commonly prescribed for:
-
Multiple Myeloma
-
Mantle Cell Lymphoma
-
Relapsed or refractory blood cancers
-
Combination cancer therapy protocols
Therefore, BORVIZ 2 plays a crucial role in improving patient outcomes.
How Does BORVIZ 2 Work?
BORVIZ 2 blocks the proteasome system inside cancer cells.
As a result:
-
Cancer cell proteins accumulate
-
Cell growth is disrupted
-
Cancer cells undergo apoptosis (programmed cell death)
This targeted action helps minimize damage to healthy cells.
Dosage and Administration
-
Dosage is decided by the oncologist
-
Administered as per treatment protocol
-
Frequency depends on patient condition and combination therapy
⚠️ Important: BORVIZ 2 should only be used under specialist medical supervision.
Possible Side Effects
Some patients may experience:
-
Fatigue
-
Nausea or vomiting
-
Peripheral neuropathy
-
Low blood cell counts
-
Diarrhea or constipation
However, side effects can be managed with proper dose adjustment and monitoring.
Precautions and Warnings
Before using BORVIZ 2, patients should inform their doctor if they have:
-
Liver or kidney disorders
-
Nerve-related problems
-
Heart conditions
-
Active infections
Regular blood tests and clinical monitoring are recommended during therapy.
Why Choose Unnati Pharmax for BORVIZ 2 Export?
Unnati Pharmax is a trusted Indian pharmaceutical exporter, supplying oncology medicines to international markets.
Our Key Advantages
-
WHO-GMP certified manufacturing partners
-
Competitive export pricing
-
Export-grade secure packaging
-
Complete documentation support
-
Reliable worldwide delivery
As a result, global buyers prefer Unnati Pharmax for cancer drug exports.
Global Export of BORVIZ 2 Tablets
We export BORVIZ 2 to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Additionally, we support importers with regulatory and logistics assistance.
Frequently Asked Questions (FAQs)
1. What is BORVIZ 2 used for?
BORVIZ 2 is used to treat multiple myeloma and mantle cell lymphoma.
2. Is BORVIZ 2 chemotherapy?
No. BORVIZ 2 is a targeted therapy, not traditional chemotherapy.
3. Can BORVIZ 2 be exported from India?
Yes. Unnati Pharmax exports BORVIZ 2 with full legal and regulatory compliance.
4. How should BORVIZ 2 be stored?
Store in a cool, dry place away from direct light.
5. Why buy BORVIZ 2 from Unnati Pharmax?
Because we ensure authentic products, quality assurance, and dependable global supply.
Conclusion
In conclusion, BORVIZ 2 Tablets are a vital targeted therapy for the treatment of multiple myeloma and related cancers. Choosing a reliable exporter ensures consistent quality and uninterrupted supply.
